256 related articles for article (PubMed ID: 18979108)
1. Preoperative assessment of basal cell carcinoma using conventional fluorescence diagnosis.
Neus S; Gambichler T; Bechara FG; Wöhl S; Lehmann P
Arch Dermatol Res; 2009 Apr; 301(4):289-94. PubMed ID: 18979108
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of fluorescence diagnosis of basal cell carcinoma using a digital flash light-based imaging system.
Gambichler T; Moussa G; Altmeyer P
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):67-71. PubMed ID: 18353085
[TBL] [Abstract][Full Text] [Related]
3. Can basal cell carcinoma lateral border be determined by fluorescence diagnosis?: Verification by Mohs micrographic surgery.
El Hoshy K; Bosseila M; El Sharkawy D; Sobhi R
Photodiagnosis Photodyn Ther; 2016 Jun; 14():4-8. PubMed ID: 26790611
[TBL] [Abstract][Full Text] [Related]
4. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery.
Stenquist B; Ericson MB; Strandeberg C; Mölne L; Rosén A; Larkö O; Wennberg AM
Br J Dermatol; 2006 Feb; 154(2):305-9. PubMed ID: 16433801
[TBL] [Abstract][Full Text] [Related]
5. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
6. Do basal cell carcinomas recur after complete conventional surgical excision?
Griffiths RW; Suvarna SK; Stone J
Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper?
Griffiths RW; Suvarna SK; Stone J
J Plast Reconstr Aesthet Surg; 2007; 60(1):41-7. PubMed ID: 17126265
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma--new aspects of diagnosis and treatment.
Wennberg AM
Acta Derm Venereol Suppl (Stockh); 2000; 209():5-25. PubMed ID: 10884941
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo.
Sandberg C; Halldin CB; Ericson MB; Larkö O; Krogstad AL; Wennberg AM
Br J Dermatol; 2008 Nov; 159(5):1170-6. PubMed ID: 18717673
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence lifetime imaging distinguishes basal cell carcinoma from surrounding uninvolved skin.
Galletly NP; McGinty J; Dunsby C; Teixeira F; Requejo-Isidro J; Munro I; Elson DS; Neil MA; Chu AC; French PM; Stamp GW
Br J Dermatol; 2008 Jul; 159(1):152-61. PubMed ID: 18460029
[TBL] [Abstract][Full Text] [Related]
11. Effect of tissue shrinkage on histological tumour-free margin after excision of basal cell carcinoma.
Blasdale C; Charlton FG; Weatherhead SC; Ormond P; Lawrence CM
Br J Dermatol; 2010 Mar; 162(3):607-10. PubMed ID: 19906070
[TBL] [Abstract][Full Text] [Related]
12. No clinical benefit of preoperative fluorescence diagnosis of basal cell carcinoma localized in the H-zone of the face.
Wetzig T; Kendler M; Maschke J; Paasch U; Simon JC
Br J Dermatol; 2010 Jun; 162(6):1370-6. PubMed ID: 20302577
[TBL] [Abstract][Full Text] [Related]
13. Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo?
Moseley H; Brancaleon L; Lesar AE; Ferguson J; Ibbotson SH
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):72-5. PubMed ID: 18353086
[TBL] [Abstract][Full Text] [Related]
14. Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics.
Seidenari S; Arginelli F; Dunsby C; French P; König K; Magnoni C; Manfredini M; Talbot C; Ponti G
Exp Dermatol; 2012 Nov; 21(11):831-6. PubMed ID: 22882324
[TBL] [Abstract][Full Text] [Related]
15. [The margin of safety and depth of excision in surgical treatment of basalioma. Use of 3-dimensional histologic study of 2,016 tumors].
Breuninger H; Schippert W; Black B; Rassner G
Hautarzt; 1989 Nov; 40(11):693-700. PubMed ID: 2606668
[TBL] [Abstract][Full Text] [Related]
16. Presence of residual basal cell carcinoma in re-excised specimens is more probable when deep and lateral margins were positive.
Fernandes JD; de Lorenzo Messina MC; de Almeida Pimentel ER; Castro LG
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):704-6. PubMed ID: 18384541
[TBL] [Abstract][Full Text] [Related]
17. Terahertz pulsed imaging of basal cell carcinoma ex vivo and in vivo.
Wallace VP; Fitzgerald AJ; Shankar S; Flanagan N; Pye R; Cluff J; Arnone DD
Br J Dermatol; 2004 Aug; 151(2):424-32. PubMed ID: 15327550
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence detection and diagnosis of non-melanoma skin cancer at an early stage.
de Leeuw J; van der Beek N; Neugebauer WD; Bjerring P; Neumann HA
Lasers Surg Med; 2009 Feb; 41(2):96-103. PubMed ID: 19226578
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence imaging for the demarcation of basal cell carcinoma tumor borders.
Alkalay R; Alcalay J; Maly A; Ingber A; Fritsch C; Ruzicka T; Enk CD
J Drugs Dermatol; 2008 Nov; 7(11):1033-7. PubMed ID: 19110733
[TBL] [Abstract][Full Text] [Related]
20. In vivo optical coherence tomography of basal cell carcinoma.
Gambichler T; Orlikov A; Vasa R; Moussa G; Hoffmann K; Stücker M; Altmeyer P; Bechara FG
J Dermatol Sci; 2007 Mar; 45(3):167-73. PubMed ID: 17215110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
